Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Open-market sale Chief Scientific Officer sold 18,167 shares at $12.12 ($220,246)
  2. 4 Open-market sale Director sold 18,167 shares at $12.12 ($220,246)
  3. 4 Open-market sale EVP, Chief Medical Officer sold 1,704 shares at $9.86 ($16,805)
  4. 4 Open-market sale EVP, Chief Dev. Officer sold 1,991 shares at $9.86 ($19,635)
  5. 4 Open-market sale EVP, CFO & Treasurer sold 3,947 shares at $9.86 ($38,925)
  6. 4 Open-market sale Director sold 13,471 shares at $9.86 ($132,851)
  7. 4 Open-market sale Chief Scientific Officer sold 13,471 shares at $9.86 ($132,851)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale SVP, Chief Business Officer sold 499 shares at $6.69 ($3,338)
  11. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 665 shares (to pay taxes)
  12. 4 Grant or award SVP Sales & Commercial Ops acquired 7,500 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale SVP, Chief Business Officer sold 528 shares at $9.29 ($4,905)
  15. 4 Grant or award EVP, CFO, Treasurer acquired 5,500 shares (grant or award)
  16. 4 Exercise or conversion SVP, Chief Business Officer acquired 1,500 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 31 · 601 filings